-+ 0.00%
-+ 0.00%
-+ 0.00%

B. Riley Securities Initiates Coverage On Palisade Bio with Buy Rating, Announces Price Target of $7

Benzinga·01/09/2026 15:11:58
Listen to the news
B. Riley Securities analyst William Woods initiates coverage on Palisade Bio (NASDAQ:PALI) with a Buy rating and announces Price Target of $7.